Advancing Organoid Engineering for Tissue Regeneration and Biofunctional Reconstruction
Biomaterials Research · 2024-01 · 28
DOI: 10.34133/bmr.0016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Research, online erschienen am 15.04.2024. Verfasst von Hairong Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou 310015, China. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 274 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang Shuren University research project.
Abstract (Originalsprache)
Tissue damage and functional abnormalities in organs have become a considerable clinical challenge. Organoids are often applied as disease models and in drug discovery and screening. Indeed, several studies have shown that organoids are an important strategy for achieving tissue repair and biofunction reconstruction. In contrast to established stem cell therapies, organoids have high clinical relevance. However, conventional approaches have limited the application of organoids in clinical regenerative medicine. Engineered organoids might have the capacity to overcome these challenges. Bioengineering—a multidisciplinary field that applies engineering principles to biomedicine—has bridged the gap between engineering and medicine to promote human health. More specifically, bioengineering principles have been applied to organoids to accelerate their clinical translation. In this review, beginning with the basic concepts of organoids, we describe strategies for cultivating engineered organoids and discuss the multiple engineering modes to create conditions for breakthroughs in organoid research. Subsequently, studies on the application of engineered organoids in biofunction reconstruction and tissue repair are presented. Finally, we highlight the limitations and challenges hindering the utilization of engineered organoids in clinical applications. Future research will focus on cultivating engineered organoids using advanced bioengineering tools for personalized tissue repair and biofunction reconstruction.
Autor:innen und Institutionen
- Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou 310015, China.
- The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325200, China.
- Ningxia Medical University, Ningxia 750004, China.
- Department of Biology, The Johns Hopkins University, Baltimore, MD 21218, USA.
ORCID-Profile: Hairong Jin, Zengqi Xue, Jinnv Liu, Binbin Ma, Jianfeng Yang, Lanjie Lei
Förderung
- Zhejiang Shuren University research project
Zitieren
APA
Jin, H., Xue, Z., Liu, J., Ma, B., Yang, J., & Lei, L. (2024). Advancing Organoid Engineering for Tissue Regeneration and Biofunctional Reconstruction. Biomaterials Research, 28. https://doi.org/10.34133/bmr.0016
Vancouver
Jin H, Xue Z, Liu J, Ma B, Yang J, Lei L. Advancing Organoid Engineering for Tissue Regeneration and Biofunctional Reconstruction. Biomaterials Research. 2024;28. doi:10.34133/bmr.0016
BibTeX
@article{Jin2024,
author = {Jin, Hairong and Xue, Zengqi and Liu, Jinnv and Ma, Binbin and Yang, Jianfeng and Lei, Lanjie},
title = {Advancing Organoid Engineering for Tissue Regeneration and Biofunctional Reconstruction},
journal = {Biomaterials Research},
year = {2024},
volume = {28},
doi = {10.34133/bmr.0016}
}
EUVIMED